Cetera Advisors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$1.35M Buy
12,669
+8,419
+198% +$897K 0.01% 1010
2023
Q4
$423K Sell
4,250
-1,184
-22% -$118K 0.01% 1222
2023
Q3
$561K Buy
5,434
+173
+3% +$17.9K 0.01% 995
2023
Q2
$639K Sell
5,261
-13
-0.2% -$1.58K 0.01% 926
2023
Q1
$810K Sell
5,274
-351
-6% -$53.9K 0.01% 781
2022
Q4
$1.01M Buy
5,625
+484
+9% +$86.9K 0.02% 667
2022
Q3
$608K Sell
5,141
-802
-13% -$94.8K 0.02% 697
2022
Q2
$849K Buy
5,943
+296
+5% +$42.3K 0.02% 628
2022
Q1
$973K Sell
5,647
-7,746
-58% -$1.33M 0.02% 621
2021
Q4
$3.4M Sell
13,393
-1,430
-10% -$363K 0.07% 283
2021
Q3
$5.71M Buy
14,823
+867
+6% +$334K 0.11% 190
2021
Q2
$3.28M Sell
13,956
-516
-4% -$121K 0.08% 256
2021
Q1
$1.9M Buy
14,472
+489
+3% +$64K 0.05% 329
2020
Q4
$1.46M Buy
13,983
+1,223
+10% +$128K 0.05% 337
2020
Q3
$903K Buy
12,760
+418
+3% +$29.6K 0.03% 392
2020
Q2
$792K Buy
+12,342
New +$792K 0.03% 420